Correlations of the biochemical and clinical effects of 6-azauridine in patients with leukemia
- 1 October 1962
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 33 (4) , 526-537
- https://doi.org/10.1016/0002-9343(62)90263-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- THE URICOSURIA AND OROTIC ACIDURIA INDUCED BY 6-AZAURIDINE*Journal of Clinical Investigation, 1961
- PYRIMIDINE METABOLISM IN MAN. IV. THE ENZYMATIC DEFECT OF OROTIC ACIDURIA*Journal of Clinical Investigation, 1961
- Inhibition of orotidylic acid decarboxylase, a primary site of carcinostasis by 6-azauracilBiochimica et Biophysica Acta, 1958
- The anti-tumour activity of 6-azauracil ribosideCellular and Molecular Life Sciences, 1958
- Mechanism of the cancerostatic action of 6-azauracil and its ribosideCollection of Czechoslovak Chemical Communications, 1958
- Treatment of Chronic Granulocytic Leukemia with MyleranNew England Journal of Medicine, 1957
- Myleran Treatment in Chronic Granulocytic LeukaemiaBritish Journal of Haematology, 1957
- The anticancerous action of 6-azauracil (3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine)Cellular and Molecular Life Sciences, 1956
- Treatment of Chronic Granulocytic Leukemia with 1,4-Dimethanesulfonyloxybutane (Myleran)New England Journal of Medicine, 1956
- MYLERAN IN CHRONIC MYELOID LEUKÆMIAThe Lancet, 1955